Trials / Completed
CompletedNCT06429943
Cerebrolysin in SAH (Subarachnoidal Haemorrhage) - Observational Study
Cerebrolysin in Patients Diagnosed With SAH - an Observational Cohort Study (PILOT)
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 47 (actual)
- Sponsor
- Pomeranian Medical University Szczecin · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Subarachnoid haemorrhage often affects people in middle age and is associated with high mortality or neurological damage. In recent years, advances in surgical techniques have im-proved the mortality rate. However, there is still need for the research for the optimal possible final effect of treatment. In our study, we've decided to examine the effect of a multimodal approach including Cerebrolysin in the supportive treatment of patients. We've examined the supply of neuroprotective drugs and neuromonitoring.
Conditions
Timeline
- Start date
- 2021-01-15
- Primary completion
- 2022-10-15
- Completion
- 2023-01-10
- First posted
- 2024-05-28
- Last updated
- 2024-05-28
Locations
1 site across 1 country: Poland
Source: ClinicalTrials.gov record NCT06429943. Inclusion in this directory is not an endorsement.